Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mross

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Onkologie|June 1, 1982
[Leukocyte migration inhibition test using myelin basic protein in patients with malignant diseases]K Mross, B Mross, D I Wolfrum
Oncology|January 1, 1985
Determination of tissue polypeptide antigen (TPA) levels in different cancer types and controlsK B Mross, D I Wolfrum, H Rauschecker
Pneumologie (Stuttgart, Germany)|December 9, 2016
P Löser, B Mross, H Lapp, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1980
The electrophoretic mobility test with myelin basic protein, binding of 125I-MBP to lymphocytes, and gel electrophoresis pattern of supernatant during incubationK Mross, B Mross, D I Wolfrum, et al.
Klinische Wochenschrift|May 2, 1983
Determination of TPA levels in breast cancer and controlsK Mross, B Mross, D I Wolfrum, et al.
Onkologie|October 1, 1990
[Iodo-doxorubicin, a new anthracycline derivative. Current state of progress]K B Mross, T Langenbuch, K Burk, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Metabolism of epidoxorubicin in animals: absence of glucuronidationP A Maessen, K B Mross, H M Pinedo, et al.
Journal of Chromatography|July 3, 1987
Improved method for the determination of 4'-epidoxorubicin and seven metabolites in plasma by high-performance liquid chromatographyP A Maessen, K B Mross, H M Pinedo, et al.
Journal of Chromatography|January 22, 1988
New method for the determination of doxorubicin, 4'-epidoxorubicin and all known metabolites in cardiac tissueP A Maessen, H M Pinedo, K B Mross, et al.
Onkologie|June 1, 1990
Phase II evaluation of carboplatin in advanced esophageal carcinoma. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer SocietyW Queisser, P Preusser, K B Mross, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Onkologie|June 1, 1982
[Leukocyte migration inhibition test using myelin basic protein in patients with malignant diseases]K Mross, B Mross, D I Wolfrum
Oncology|January 1, 1985
Determination of tissue polypeptide antigen (TPA) levels in different cancer types and controlsK B Mross, D I Wolfrum, H Rauschecker
Pneumologie (Stuttgart, Germany)|December 9, 2016
P Löser, B Mross, H Lapp, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1980
The electrophoretic mobility test with myelin basic protein, binding of 125I-MBP to lymphocytes, and gel electrophoresis pattern of supernatant during incubationK Mross, B Mross, D I Wolfrum, et al.
Klinische Wochenschrift|May 2, 1983
Determination of TPA levels in breast cancer and controlsK Mross, B Mross, D I Wolfrum, et al.
Onkologie|October 1, 1990
[Iodo-doxorubicin, a new anthracycline derivative. Current state of progress]K B Mross, T Langenbuch, K Burk, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Metabolism of epidoxorubicin in animals: absence of glucuronidationP A Maessen, K B Mross, H M Pinedo, et al.
Journal of Chromatography|July 3, 1987
Improved method for the determination of 4'-epidoxorubicin and seven metabolites in plasma by high-performance liquid chromatographyP A Maessen, K B Mross, H M Pinedo, et al.
Journal of Chromatography|January 22, 1988
New method for the determination of doxorubicin, 4'-epidoxorubicin and all known metabolites in cardiac tissueP A Maessen, H M Pinedo, K B Mross, et al.
Onkologie|June 1, 1990
Phase II evaluation of carboplatin in advanced esophageal carcinoma. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer SocietyW Queisser, P Preusser, K B Mross, et al.
Pageof 2